Relaxin-3 (RLN3) is a neuropeptide that is strongly expressed in the pontine nucleus incertus (NI) and binds with high affinity to its cognate receptor RXFP3. Central administration of RLN3 in rats increases food intake and adiposity. In humans, RLN3 polymorphism has been associated with obesity and hypercholesterolaemia. Emerging evidence suggests that the effects of RLN3 may have sex-specific aspects. Thus, the RLN3 knockout female but not male mice are hypoactive. RLN3 produced stronger orexigenic and obesogenic effects in female rats compared with male rats. In addition, female rats demonstrated higher sensitivity to lower doses of RLN3. Repeated cycles of food restriction and stress were accompanied by an increase in RLN3 expression and hyperphagia in female but not in male rats. Furthermore, stress-induced binge eating in female rats was blocked by an RXFP3 receptor antagonist. RLN3 increased the expression of corticotropin releasing factor in the paraventricular hypothalamic nucleus in male but not in female rats. Conversely, in female rats, RLN3 increased the expression of orexin in the lateral hypothalamus. There is evidence that orexin directly activates the RLN3 neurons in the NI. The positive reinforcement of the RLN3 effects by orexin may intensify behavioural activation and feeding in females. Sex-specific effects of RLN3 may also depend on differential expression of RXFP3 receptors in the brain. Given the higher sensitivity of females to the orexigenic effects of RLN3 and the stress-induced activation of RLN3, the overall data suggest a possible role for RLN3 in eating disorders that show a higher propensity in women.
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Introduction
Relaxin-3 (RLN3), also known as insulin-like peptide 7 (INSL7), is a two-chain peptide of the relaxin peptide family that also includes structurally related peptides RLN1, RLN2 (also known as relaxin), and INSL3, INSL4, INSL5 and INSL6 . The relaxin family peptides, according to their high structural similarity to insulin, are members of the relaxin/insulin superfamily, which also contains insulinlike growth factors (Bathgate et al., 2002; Liu et al., 2003b; Wilkinson et al., 2005; Liu and Lovenberg, 2008) . In contrast to other members of relaxin/insulin superfamily peptides, RLN3 is mainly produced in the central nervous system (Smith et al., 2011) . In the brain, RLN3 is strongly expressed in the pontine nucleus incertus (NI) and activates its native relaxin family peptide receptor 3 (RXFP3) (Bathgate et al., 2006a) , and can also bind with lower affinity to RXFP1 and RXFP4 receptors, the latter is a non-functional pseudogene in rats (Liu et al., 2003a,b; Chen et al., 2005; Bathgate et al., 2013) . In humans, RLN3 polymorphism has been associated with obesity, hypercholesterolaemia and diabetes (Munro et al., 2011) , suggesting that RLN3 signalling is involved in the regulation of energy metabolism. The orexigenic and obesogenic effects of RLN3 have been mainly investigated in male rodents. In male rats, an increase in food intake was noted after acute intracerebroventricular (i.c.v.) injection of RLN3 (McGowan et al., 2005 (McGowan et al., , 2006 (McGowan et al., , 2007 , and accumulating epididymal fat mass and an increase in body weight (BW) gain were observed after chronic central administration of the neuropeptide (Hida et al., 2006) . Accordingly, RLN3 knockout male mice showed slower recovery of BW after chronic stress compared with their wild-type littermates . Emerging evidence suggests that the effects of RLN3 may also have sex-specific aspects. Female but not male RLN3 knockout mice were found to be hypoactive . Direct i.c.v. injections of RLN3 revealed a higher food intake and more BW gain in response to higher doses of the neuropeptide in female rats compared with male rats (Lenglos et al., 2015; Calvez et al., 2015b) . Moreover, female rats showed higher sensitivity to lower doses of RLN3 (Lenglos et al., 2015) . Central administration of RLN3 induced sex-specific differences in the activation of the hypothalamic-pituitary adrenal (HPA) axis, including higher activation of corticotropin releasing factor (CRF) neurons in the paraventricular hypothalamic nucleus (PVN) in male than in female rats (Lenglos et al., 2015) . Female rats also displayed higher BW gain and adiposity after 2 weeks of continuous i.c.v. administration of RLN3 (Calvez et al., 2015a) . In addition, repeated cycles of food restriction, intermittent access to palatable food and stress were accompanied by an increase in RLN3 expression in the NI and hyperphagia in female but not in male rats (Lenglos et al., 2013) . Furthermore, the stress-induced overexpression of RLN3 in the NI of binge eating prone (BEP) female rats was accompanied by episodes of sucrose binge eating (Calvez et al., 2016) . Stressinduced binge eating of sucrose in BEP female rats was prevented by i.c.v. administration of a specific RXFP3 receptor antagonist (Calvez et al., 2016) . Moreover, female rats that exhibited increased expression of RLN3 in the NI demonstrated lower activation of the HPA axis in response to stress (Lenglos et al., 2013; Calvez and Timofeeva, 2016; Calvez et al., 2016) . An imbalance in the activity of the HPA axis is directly related to the development of eating disorders (Lo Sauro et al., 2008; Timofeeva and Calvez, 2014) . The prevalence of eating disorders is particularly high in women (Woodside et al., 2001) . In fact, eating disorders affect disproportionately more women than men, with the female-to-male ratio ranging from 3:1 to 10:1 (Hoek, 2006; Hudson et al., 2007; Preti et al., 2009) . As a result, 93% of individuals hospitalized each year for eating disorders are women (PHAC, 2002) . Negative mood and life stress events are the most common antecedents of binge eating episodes in eating disorders (Cattanach et al., 1988; Crowther et al., 2001; Smyth et al., 2007; Berg et al., 2015) , and emotional eating has been significantly associated with obesity in women but not among men (Laitinen et al., 2002) . Given that the expression of RLN3 is up-regulated by stress (Tanaka et al., 2005) and also that females are more sensitive to the orexigenic effects of RLN3 (Lenglos et al., 2015; Calvez et al., 2015b) , RLN3 may have a role in the development of eating disorders that shows a higher propensity in women than in men. The objectives of this review are to present evidence of the Neuropeptide Y Testosterone sex-specific effects of RLN3 on food intake and BW gain and to discuss the potential sex-specific brain mechanisms triggered by this neuropeptide.
Relaxin-3 and its cognate receptor, RXFP3
RLN3 is a 6-kDa neuropeptide that was discovered in 2001 (Bathgate et al., 2002) . It belongs to the relaxin/insulin superfamily of peptides; like the other members of this family, RLN3 consists of two disulphide bonds linking its A-and B-chains and an additional intra-A chain connection . The receptors of the relaxin family peptides are G protein-coupled receptors , and the cognate receptor of RLN3 is RXFP3 (Liu et al., 2003a,b) . However, RLN3 also binds to the RXFP1 receptor, the cognate receptor of relaxin, and RXFP4 receptors (Sudo et al., 2003; Liu et al., 2003a; Bathgate et al., 2006b) . Because the RXFP4 gene is a non-functional pseudogene in rats (Chen et al., 2005) , RLN3 signals may be mediated only by RXFP1 and RXFP3 receptors in the rat brain. However, the affinity of RLN3 to its cognate receptor RXFP3 is about 10 times higher than that for RXFP1 (Liu et al., 2003a,b) . Importantly, the RXFP3 receptor does not bind human relaxin or any other peptides of the relaxin/insulin superfamily (Liu et al., 2003a) . Unlike the other relaxins, RLN3 homology is well conserved across species, suggesting highly preserved and critical biological roles (Wilkinson et al., 2005) . Activation of the RXFP3 receptor stimulates ERK 1/2 and inhibits cAMP accumulation via inhibitory Gα i/o -protein coupling (Liu et al., 2003b; van der Westhuizen et al., 2007) . Conversely, activation of the RXFP1 receptor leads to the accumulation of cAMP via initial activation of the Gα s component (Halls et al., 2006) . The expression of the RXFP1 receptor in different brain regions is generally associated with excitatory neurons while the expression of the RXFP3 receptor is mainly associated with inhibitory neurons . Furthermore, in contrast to RXFP3 receptors, activation of RXFP1 receptors by relaxin is associated with an inhibitory effect on food intake in male rats (McGowan et al., 2010) . The expression of RLN3 and RXFP3 receptors is almost exclusively confined to the brain (Sutton et al., 2004; Tanaka et al., 2005; Ma et al., 2007; Smith et al., 2010) , and only limited peripheral expression has been demonstrated (Liu et al., 2003b; Yamamoto et al., 2014) . Neuroanatomical studies conducted in rodents have demonstrated that RLN3 is strongly expressed within neurons of the NI, while smaller and more diffuse populations are also present in the pontine raphe, the anterior periaqueductal gray and in a region dorsal to the substantia nigra (Tanaka et al., 2005; Ma et al., 2007; Smith et al., 2010) . The implication of the different subpopulations of RLN3 neurons to food intake regulation requires further investigation because viral vector-driving silencing of RLN3 expression limited to the NI did not affect food intake and BW gain in male rats (Callander et al., 2012) . From the brainstem, the RLN3 neurons widely project to the hypothalamus, septum, cortical and limbic brain regions (Tanaka et al., 2005; Ma et al., 2007; Smith et al., 2010) . Histochemistry, in situ hybridization and autoradiography have shown that the distribution of RXFP3 receptor mRNA and its binding sites largely overlap the distribution of RLN3-positive axonal terminals (Sutton et al., 2004; Tanaka et al., 2005; Ma et al., 2007; Smith et al., 2010) . Hence, high densities of RLN3 fibres and RXFP3 receptor mRNA have been observed in a number of forebrain areas including the hypothalamic regions such as the PVN, the supraoptic nucleus (SON), the lateral hypothalamic area (LHA), the arcuate nucleus (ARC), the central and medial amygdala, preoptic area and the bed nucleus of the stria terminalis (BNST) (Smith et al., 2011) . The nuclei of the hypothalamus, amygdala and BNST play important roles in energy homeostasis and the stress response (Cullinan et al., 1993; Richard and Timofeeva, 2009; Petrovich, 2011) ; accordingly, many studies have demonstrated that RLN3/RXFP3 receptor signalling is involved in the regulation of energy metabolism and feeding (McGowan et al., 2005 (McGowan et al., , 2006 Hida et al., 2006; Ganella et al., 2013; Lenglos et al., 2015) , motivated behaviours (Ryan et al., 2013b (Ryan et al., , 2014 Smith et al., 2014) and stress and anxiety (Tanaka et al., 2005; Smith et al., 2009; Watanabe et al., 2011a; Lenglos et al., 2013; Ryan et al., 2013a; McGowan et al., 2014) .
Effect of relaxin-3 on food intake and body weight in rats and evidence of the sex-specific differences
Since its discovery, RLN3 has been shown to have an important role in regulating food intake in behavioural studies (Ganella et al., 2012) . The central administration of RLN3 strongly stimulates feeding in satiated rats. Direct i.c.v. injection of RLN3 increased food intake in male rats for 1 h following its administration in either the early light or dark phases (McGowan et al., 2005; Lenglos et al., 2015) . A similar increase in food intake has been demonstrated after the i.c.v. administration of specific agonists of the RXFP3 receptor, and this effect can be reversed by the co-administration of specific antagonists of the RXFP3 receptor (Kuei et al., 2007; Haugaard-Kedstrom et al., 2011; Shabanpoor et al., 2012) . Furthermore, the i.c.v. administration of relaxin, a native ligand of RXFP1 receptors, did not affect food consumption during the light phase (McGowan et al., 2005) and decreased food intake during the dark phase in male rats (McGowan et al., 2010) . However, the anorectic effects of relaxin may be secondary to other altered behaviours such as grooming or drinking (McGowan et al., 2010) . These results indicate that the RXFP1 receptor is not involved in the stimulation of food intake. Taken together, the evidence suggests that the orexigenic effect of RLN3 is specifically mediated by RXFP3 receptors. In addition, RLN3 appears to be involved in the motivational drive to eat. In male rats, the expression of RLN3 in the NI has been shown to be positively correlated with the intake of rewarding substances, such as sucrose or alcohol (Ryan et al., 2013b; Ryan et al., 2014) , and food restriction stimulated the expression of RLN3 in the NI (Lenglos et al., 2014) . The neuronal populations that mediate the orexigenic effects of RLN3 include several hypothalamic regions that express RXFP3 receptors, because micro-infusions of RLN3 into the PVN, ARC, SON or anterior preoptic area strongly stimulated feeding (McGowan et al., 2005 (McGowan et al., , 2006 (McGowan et al., , 2007 .
RLN3 has also been shown to affect BW and adiposity in male rats. Thus, chronic i.c.v. administration of RLN3 over 2 weeks induced hyperphagia and produced a significant increase in BW and epididymal fat mass in male rats (Hida et al., 2006) . These results were replicated with chronic i.c.v. injection of a RXFP3 receptor agonist . Male rats with virally-induced hypothalamic overexpression of an agonist of RXFP3 receptors (Ganella et al., 2013) or with sub-chronic intra-PVN injections of RLN3 (McGowan et al., 2006 ) also displayed higher BW and greater food intake compared with the control groups. Male and female rats showed a significant increase in BW and 50-70% increase in the inguinal subcutaneous white adipose tissue (WAT) and 65-75% increase in the visceral retroperitoneal WAT after 2 weeks of i.c.v. administration of RLN3. Moreover, female but not male rats displayed a significant (125% higher compared with the vehicle-treated female rats) increase in the perigonadal WAT after chronic i.c.v. administration of RLN3 (Calvez et al., 2015a) . The RLN3-induced increase in BW and fat mass appears to occur without overall changes in energy expenditure in male rats. Acute PVN injections of RLN3 did not affect the VO 2 in male rats (McGowan et al., 2006) , and chronic i.c.v. injections of RLN3 or hypothalamic overexpression of an RXFP3 agonist did not modify locomotor activity (Hida et al., 2006; Ganella et al., 2013) . No difference was detected in brown adipose tissue (BAT) mass or in BAT uncoupling protein-1 (UCP-1) mRNA expression after subchronic intra-PVN injections of RLN3 in male rats, suggesting no significant effects of RLN3 on thermogenesis (McGowan et al., 2006) . The lack of a difference in the BW of intra-PVN RLN3-infused rats compared with their pair-fed controls further supports the hypothesis that RLN3 has little impact on energy expenditure (McGowan et al., 2006) , and the obesogenic effects of RLN3 mainly depend on its orexigenic effects in rats.
In an animal model of obesity induced by a palatable, high-energy diet, the central expression of RLN3 and RXFP3 receptors has been found to be abnormal (Lenglos et al., 2014) . Diet-induced obese male rats displayed significantly higher levels of RLN3 expression compared with dietresistant rats in an ad libitum feeding state. This increased expression of RLN3 in diet-induced obese rats may contribute to the hyperphagia observed in this phenotype. During a metabolic challenge of refeeding after food deprivation, the diet-induced obese but not diet-resistant rats exhibited increased expression of RXFP3 receptors in brain regions involved in food intake regulation such as the parvocellular part of the PVN, the central amygdala, the NI and the nucleus of the solitary tract (Lenglos et al., 2014) . In addition, the paraventricular thalamic nucleus, an important relay structure connecting the hypothalamic food-regulating centres with the limbic and reward forebrain regions (Kelley et al., 2005) , expressed higher levels of RXFP3 receptor mRNA in refed, diet-induced obese rats compared with all other groups (Lenglos et al., 2014) . The increased level of expression of RXFP3 receptors in diet-induced obese rats may help to defend an elevated BW set point in an obese phenotype against metabolic challenges.
It is important to note that in contrast to rats, i.c.v. or intra-PVN injections of RXFP3 receptor agonists did not increase feeding in satiated or mildly food-deprived mice (Smith et al., 2014) . In addition, two independent studies found that a deficiency in RLN3 had no effect on BW in male and female mice Watanabe et al., 2011b) . However, blockade of the RXFP3 receptor by antagonist injections reduced the palatable food intake and motivation to eat in mice (Smith et al., 2014) . Therefore, in mice, RLN3 does not exhibit a strong orexigenic effect but may be involved in motivated behaviours associated with food seeking. These between-species variations indicate a possible difference in the basal activity of RLN3 or of the levels of RXFP3 receptors expressed in the food intake-regulating areas in the mouse and rat brain.
Most studies on the effects of RLN3 and its receptor RXFP3 on food intake and BW have involved male rodents. However, accumulating evidence suggests that the regulation of expression of RLN3 and RXFP3 receptors in the brain and their effects on behavioural activation, food intake and BW gain are sex-specific. The first evidence of sex-specific differences in the involvement of RLN3 in behavioural activation was obtained in a study involving RLN3 knockout male and female mice ). Female but not male RLN3 knockout mice showed hypoactivity in behavioural tests such as in the locomotor cell, large open field, Y-maze and novel object test as well as demonstrating fewer social interactions with a novel mice ). This hypoactivity in female RLN3-deficient mice was not related to a motor deficit, as there were no genotype differences in latencies to fall from an accelerating rotarod, but suggested a different sex-specific effect of RLN3 in circuits involved in arousal, exploration and behavioural activation . The sex-specific regulation of the expression of RLN3 in rats has been demonstrated in a study involving repeated weekly cycles of food restriction, intermittent access to highly palatable food, and a restraint stress (Lenglos et al., 2013) . This treatment produced sex-specific effects on food intake and BW gain by inducing hyperphagia and an increase in BW in female but not in male rats. Moreover, hyperphagic female rats with a history of repeated food restriction and stress displayed a significantly higher level of RLN3 expression in the NI compared with all other groups (Lenglos et al., 2013) . This result suggests that RLN3 might have a sex-specific role in food intake and BW regulation. To test this hypothesis, a series of acute i.c.v. administrations of RLN3 were conducted in male and female rats (Lenglos et al., 2015; Calvez et al., 2015b) . Female rats demonstrated a higher sensitivity to low doses of RLN3 and also a significantly higher food intake at higher doses of the injected neuropeptide compared with male rats (Figure 1) (Lenglos et al., 2015) . Accordingly, the 24-h BW gain was significantly increased after the i.c.v. administration of 800 pmol RLN3 in female but not in male rats (Figure 2) (Lenglos et al., 2015) . Importantly, sex-specific effects of RLN3 on food intake were evident not only in absolute values (in g of chow eaten) but also in values relative to BW (rat chow eaten in mg·g À1 BW) (Lenglos et al., 2015) . The experiments involved young adult rats of 7-12 weeks of age. At this age, the dynamics of BW gain are different in male and female Sprague Dawley rats. Male and female rats of 7-12 weeks of age increase their BW to about 50 and 10 g·week À1 respectively (Aleman et al., 1998) . Given the age-specific expression of the RXFP3 receptor in the brain (Meadows and Byrnes, 2015) , additional experiments are warranted to assess the effects of RLN3 on food intake in rats after the relative stabilization in BW gain. In the context of age-related effects, it would also be interesting to test the expression of RLN3 and BJP J Calvez et al.
its receptor in senescent rats in relation to the reported decline in food intake, the loss of motivation to eat and geriatric cachexia in the elderly population (Donini et al., 2003; Yaxley et al., 2012) . Notwithstanding the different dynamics of BW gain in male and female young adult rats, the experiments clearly showed stronger orexigenic effects of RLN3 in female rats compared with male rats when food intake was assessed in absolute values or relative to BW values in comparison with the control, vehicle-treated rats in each sex. In addition to sex-specific effects of acute RLN3 injections, chronic central administration of RLN3 induced a significantly greater BW gain and adiposity in female rats when compared with male rats (Calvez et al., 2015a). After 2 weeks of i.c.v. administration of 400 pmol·day À1 of RLN3, female rats displayed a greater BW gain ( Figure 3 ) and a higher increase in perigonadal WAT weight than male rats. In summary, acute and chronic central injections of RLN3 indicated that female rats are more sensitive to the effects of RLN3 on food intake and BW gain.
The possible mechanisms of the sex-specific effects of RLN3
The neuronal mechanisms underlying the effects of RLN3/RXFP3 receptors on the control of feeding and BW are not yet fully understood. No effect of RLN3 or RXFP3 receptor agonists has been observed on the expression of key neuropeptides in the ARC nucleus involved in the regulation of feeding (Schwartz et al., 2000) such as pro-opiomelanocortin, neuropeptide Y and agouti-related protein (McGowan et al., 2005; Ganella et al., 2013) . Evidence suggests that the inhibition of the anorexigenic neuropeptide oxytocin in the PVN might be involved in the RLN3 orexigenic effect in male rats (Ganella et al., 2013) . However, the sex-specific effects of RLN3 on food intake and BW gain may include multiple and interrelated mechanisms in rats. The analysis of RLN3-induced expression of c-fos, a marker of neuronal activation, and the neuropeptides involved in energy homeostasis regulation suggests that CRF in the PVN and BNST and orexin in the LHA might be involved in differential orexigenic and obesogenic effects of RLN3 in male and female rats ( Table 1 in Lenglos et al. (2015) .
Figure 3
Total BW gain (in folds to the mean of the respective CSF control group) in male and female rats (n = 6 per group) injected with i.c.v. CSF or 400 pmol·day À1 of RLN3 for 14 days (reported in Calvez et al., 2015a). *P < 0.05: significantly different compared with the CSF group of the same sex; # P < 0.05: significantly different compared with the male rats in the same treatment condition.
Figure 2
Twenty-four-hour BW gain (in folds to the mean of the respective CSF control group) in male and female (n = 9 per group) rats that received i.c.v. injection of CSF or 25, 200 and 800 pmol of RLN3. *P < 0.05: significantly different compared with the CSF group of the same sex. The bar graphs present the results reported in Table 1 in Lenglos et al. (2015) .
RLN3 neurons project to the PVN, where the expression of RXFP3 receptors is abundant and might thus modulate the HPA axis responses to stress (Sutton et al., 2004; Tanaka et al., 2005; Ma et al., 2007) . The parvocellular neurons of the PVN are the key component of the HPA axis (Herman and Cullinan, 1997; Richard and Timofeeva, 2009) . From the parvocellular PVN neurons, CRF is secreted to the anterior pituitary, where it stimulates the production and release of adrenocorticotropic hormone (ACTH), which, in turn, triggers the production and release of corticosterone from the adrenal glands. Acute stress such as body restraint or foot shock accompanied by activation of the HPA axis led to a decrease in food intake in male rats maintained on a regular diet; this anorectic effect of stress could be prevented by a blockade of the CRF receptors (Krahn et al., 1986; Smagin et al., 1999) . In male rats, central or intra-PVN administration of CRF decreased food intake and increased energy expenditure, which resulted in a sustained decrease in BW gain (Arase et al., 1988; Krahn et al., 1988; Hotta et al., 1991; Buwalda et al., 1997) . The anorexigenic effect of CRF is thought to be primarily mediated by the CRF type 2 receptor (CRF 2 receptor; Smagin et al., 1998; Pelleymounter et al., 2000; Cullen et al., 2001) . It has been shown in male rats that stress up-regulates the expression of RLN3 in the NI (Tanaka et al., 2005; Banerjee et al., 2010) , and a central injection of RLN3 induced activation of the HPA axis, which was indicated by the increased expression of CRF in the parvocellular PVN and the rapid increase in the plasma concentration of ACTH and corticosterone (Watanabe et al., 2011a; McGowan et al., 2014; Lenglos et al., 2015) . Furthermore, acute i.c.v. injection of RLN3 led to an increased expression of c-fos in the PVN (Watanabe et al., 2011a; Lenglos et al., 2015; Calvez et al., 2015b) , and some of the c-fos-positive cells have been identified as CRF-expressing neurons in male rats (Watanabe et al., 2011a) . However, in female rats, no increase in plasma levels of corticosterone, CRF or c-fos expression in the parvocellular PVN was observed after acute i.c.v. administration of RLN3, suggesting that RLN3 did not activate the HPA axis in female rats (Lenglos et al., 2015; Calvez et al., 2015b) . The sex-specific effect of RLN3 on the activation of the HPA axis in male and female rats may be involved in the differential orexigenic effects of RLN3. Hence, RLN3-induced activation of the anorexigenic CRF neurons in the parvocellular PVN in male rats may interfere with its orexigenic and obesogenic effects, resulting in a significantly lower increase of food intake and BW gain in male rats when compared with female rats.
Female and male rats also displayed differential CRF expression in the BNST after acute i.c.v. injection of RLN3 (Lenglos et al., 2015) . Indeed, in female but not in male rats, central RLN3 injection induced a significant increase in CRF expression in the ventral and dorsal parts of the BNST (Lenglos et al., 2015) . The BNST is an important nucleus for the expression of motivated behaviours, and CRF neurons in the BNST are involved in the reinstatement of drug-and alcohol-seeking (Erb and Stewart, 1999; Wang et al., 2006; Silberman et al., 2013) . In a model of binge eating induced by frustration stress in female rats with a history of repeated food restriction, c-fos expression was markedly increased in the BNST, and the systemic administration of a CRF 1 receptor antagonist blocked stress-induced binge eating (Micioni Di Bonaventura et al., 2014) . Replication of this result with i.c.v. or intra-BNST injections of a non-selective CRF receptor antagonist suggested that CRF signalling in the BNST might mediate stress-induced palatable food intake (Micioni Di Bonaventura et al., 2014) . A sex-specific increase in CRF expression in the BNST of female rats (Lenglos et al., 2015) could also indicate a possible mechanism of the binge-like eating of sucrose induced by stress in BEP female rats (Calvez et al., 2016) . The BEP rats displayed a higher expression of RLN3 in the NI in stressful conditions compared with binge eating resistant rats (Calvez et al., 2016) . Moreover, i.c.v. administration of a specific RXFP3 receptor antagonist completely reversed stress-induced binge eating episodes in the BEP rats (Calvez et al., 2016) . The involvement of CRF signalling and its interaction with the RLN3 system in female BEP rats require further investigation; however, these results provide evidence for the important role of RLN3/RXFP3 receptor signalling in stress-induced palatable food intake. A correlation of RLN3 expression in the NI with sucrose consumption in male rats also supports this hypothesis (Ryan et al., 2014) . Considering the abundant projections of NI RLN3 neurons to the BNST and the high expression of RXFP3 receptors in this nucleus (Sutton et al., 2004; Ma et al., 2007) , the BNST may be involved in the effects of RLN3 on motivation to eat. Accordingly, direct bilateral injections of a RXFP3 receptor antagonist in the BNST significantly decreased self-administration and stress-induced reinstatement of alcohol intake in male rats (Ryan et al., 2013b) . Hence, an increase in RLN3-induced CRF expression in the BNST of female rats (Lenglos et al., 2015) may enhance the motivation for food and reward seeking and reinforce the orexigenic effects of RLN3 in female rats.
Chronic virally-induced hyperproduction of an RXFP3 receptor agonist in the hypothalamus was accompanied by a decrease in the hypothalamic expression of the anorexigenic neuropeptide oxytocin (Ganella et al., 2013) . In contrast, acute i.c.v. infusions of RLN3 induce an up-regulation of the levels of hypothalamic oxytocin in rats (Nakazawa et al., 2013; Calvez et al., 2015b) . This discrepancy may be the result of differential effects of acute and chronic administration of RXFP3 receptor agonists or indicate that indirect activation of oxytocin neurons occurs after i.c.v. administration of RLN3.
Acute i.c.v. RLN3 administration did not produce sexspecific effects on oxytocin expression in the magnocellular PVN neurons (Calvez et al., 2015b) . However, these results represent the combined effects of RLN3 in female rats during the prooestrus, metoestrus and dioestrus but not the oestrus phases of the oestrous cycle (Calvez et al., 2015b) . The levels of expression of oxytocin and its receptor in the brain significantly fluctuate across the oestrous cycle (Levin and Sawchenko, 1993; Bale et al., 1995) . Moreover, the effects of stress on the hypothalamic expression of oxytocin depend on the phase of the oestrous cycle (Lu et al., 2015) . Future experiments should investigate the effects of acute and chronic administration of RLN3 across all the phases of the oestrous cycle. A possible interaction of these neuropeptides may have an important behavioural effect given the role of oxytocin and RLN3 in stress responses, the regulation of food intake and binge eating in female rats (Mitra et al., 2010; Olszewski et al., 2010; Calvez et al., 2016) .
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After the i.c.v. administration of RLN3, c-fos expression was found to be increased in the LHA in female rats but not in male rats (Calvez et al., 2015b) . RLN3 neurons project from the NI to the LHA (Tanaka et al., 2005; Ma et al., 2007) , and RXFP3 receptors are expressed in this region (Sutton et al., 2004) . However, direct injections of RLN3 into the LHA of male rats did not increase their food intake (McGowan et al., 2007) , suggesting that this region is not directly involved in the orexigenic effect of RLN3, at least in male rats. In female rats, the expression of orexin, following i.c.v. injection of RLN3, was significantly up-regulated in the LHA but not in the perifornical area whereas no difference was observed between RLN3-injected and control male rats in both the LHA and the perifornical area (Calvez et al., 2015b) . The expression of orexin is modulated by the oestrous cycle in females (Wang et al., 2003; Porkka-Heiskanen et al., 2004) , and it is an orexigenic neuropeptide that increases food intake by stimulating food motivation and reward seeking (Tsujino and Sakurai, 2009; Barson et al., 2013) along with an enhancement of arousal and wakefulness (Saper, 2006) . Accumulating evidence suggests that the orexin neurons of the LHA are mainly involved in reward processing for food and drugs, whereas the orexin neurons in the perifornical area or dorsomedial hypothalamic nucleus regulate the arousal state (Estabrooke et al., 2001; Harris et al., 2005; Harris and Aston-Jones, 2006; Sakurai, 2014 ). An RLN3-induced increase in the expression of orexin in the LHA in female rats may thus enhance food motivation and reward seeking. However, the RLN3 fibres are distributed laterally to the orexinpositive neurons in the LHA, suggesting only very limited direct interaction of RLN3 and orexin neurons (Smith et al., 2013) . Excitability of the orexin neurons in the LHA may be modulated by many neurotransmitters including CRF, neurotensin, galanin or GABA (Burt et al., 2011) . The possible indirect mechanisms of stimulation of LHA orexin neurons by RLN3 in female rats may include the RLN3-induced activation of CRF expression in the BNST, which directly projects to the LHA (Wood and Swann, 2005) . Another possible mechanism may involve disinhibition of orexin neurons in the LHA by RLN3 via inhibition of galanin/GABA neurons in the ventral part of the preoptic area that project to the LHA and inhibit orexin neurons (Smith et al., 2013) . The preoptic area is densely innervated by RLN3 neurons and contains RXFP3 receptors (Sutton et al., 2004; Ma et al., 2007) , which makes this area a possible relay structure between the NI RLN3 neurons and LHA orexin neurons. However, the LHA orexin neurons directly innervate and activate the RLN3-positive NI neurons (Blasiak et al., 2015) . Therefore, it is possible that the specific effects of RLN3 on feeding are enhanced in female rats by a specific activation of orexinergic LHA neurons, followed by further activation of the reward and motivation pathways by positive reinforcement of activation of RLN3 NI neurons by orexin. This feedforward RLN3-to-orexin and feedback orexin-to-RLN3 activating cascade would be expected to result in enhanced food seeking behaviour and increased food intake in females, as orexin and RLN3 are both involved in these functions (Lin et al., 1999; Mignot, 2004; Harris et al., 2005; Scammell and Saper, 2005; Harris and Aston-Jones, 2006; Saper, 2006) .
The sex-specific effects of RLN3 may also depend on the effects of sex hormones on the expression of RLN3 and RXFP3 receptors. Analyses of the expression of mRNAs of these entities in female rats revealed that the levels of RLN3 expression in the NI decrease at prooestrus and oestrus when the plasma oestradiol level is high (De Avila et al., 2015) . Oestradiol induces anorectic effects, and food intake is significantly decreased during the oestrus phase (Asarian and Geary, 2013; Calvez and Timofeeva, 2016) . It is possible that inhibition of RLN3 expression during prooestrus and following oestrus may contribute to the anorectic effects of oestradiol. A decrease in RLN3 expression during prooestrus and oestrus was accompanied by an increase in the expression of RXFP3 receptor mRNA in the hypothalamus (De Avila et al., 2015) , which may enhance the sensitivity of female rats to exogenous and endogenous RLN3 during these phases of the oestrous cycle. Future experiments should study the direct effects of oestradiol and testosterone on the expression of RLN3 and RXFP3 receptors in ovariectomized female and orchidectomized male animals.
The first evidence for a differential pattern of expression of RXFP3 receptors in male and female rats
The sex-specific effects of RLN3 may depend on the differential expression of RXFP3 receptors in the brains of male and female rats. In a study comparing young and middle-aged rats of both sexes, sex-and age-specific differences were revealed in the mRNA and protein expression of the RXFP3 receptor in different brain regions (Meadows and Byrnes, 2015) . For example, middle-aged female rats displayed a decreased mRNA expression of RXFP3 receptors in the ventral hippocampus, and both young and middle-aged female rats had a decreased protein expression of RXFP3 receptors in hippocampus sub-regions, such as the dental gyrus in the dorsal hippocampus and the CA1 area in the ventral hippocampus (Meadows and Byrnes, 2015) . The hippocampus is a brain region important for learning and memory consolidation (Sweatt, 2004) . The NI RLN3 neurons significantly contribute to hippocampal θ rhythm activity, suggesting that the RLN3 system is involved in cognitive tasks such as learning and memory Pereira et al., 2013; Nategh et al., 2015) . Differential expression of RXFP3 receptors in the hippocampus could result in sex-specific and age-dependent effects of RLN3 on cognitive and memory functions.
No difference in the expression of RXFP3 receptor mRNA in the amygdala was found between male and female rats (Meadows and Byrnes, 2015) . However, a significant decrease in the levels of RXFP3 receptor protein was observed in the basolateral, central and medial amygdala in young and middle-aged female rats compared with male rats (Meadows and Byrnes, 2015) . Interestingly, lesions in the posterodorsal aspects of the amygdala resulted in immediate hyperphagia and moderate obesity in female rats (King et al., 1993; King et al., 1994) . Food intake returned to normal levels within a few days after the lesion procedure, but the excessive weight gain (King et al., 1996) and preference for a high-carbohydrate diet (King et al., 1998) persisted after inactivation of the amygdala in female rats. Whether RLN3/RXFP3 receptor signalling in the amygdala in female Sex-specific effects of relaxin-3 BJP rats is involved in regulating appetite and food selection remains to be investigated.
We have demonstrated that the expression of RXFP3 receptor mRNA in the PVN is higher in female rats than in male rats (Figure 4 ) (De Avila et al., 2015) . Furthermore, additional analysis across the oestrous cycle revealed that the expression of RXFP3 receptor mRNA in the magnocellular part of the PVN in female rats reached its highest levels during the prooestrus phase (De Avila et al., 2015) . Given the important role the PVN has in regulating food intake (Richard and Timofeeva, 2009 ), a higher expression of RXFP3 receptors in the PVN of female rats may explain the increased sensitivity of female rats to the orexigenic effects of RLN3. Future experiments might detect the interactive effects of stress and oestrous cycle on the expression of RXFP3 receptors in the PVN.
Conclusion
A growing body of evidence suggests that RLN3 has a sexspecific effect of on food intake and BW regulation. While RLN3 increases food intake and BW in both male and female rats, female rats are more sensitive to the effects of RLN3 and display stronger stimulation of feeding and higher BW gain in response to RLN3 administration. The mechanisms underlying the orexigenic and obesogenic effects of RLN3 are not yet fully understood; consequently, the neuronal substrates of the sex-specific effects of RLN3 are still under investigation. However, it seems that the reduced expression of anorexigenic CRF in the PVN and lower activation of the HPA axis, increased CRF expression in the BNST involved in the motivation for eating and increased expression of the orexigenic neuropeptide orexin in the LHA in female rats might be involved in their higher sensitivity to the orexigenic effects of RLN3 ( Figure 5) . Future experiments will delineate the possible interactions between the signalling pathways involved in the sex-specific effects of RLN3. The initial findings demonstrating the differential expression of RXFP3 receptors in male and female rats suggest that the pattern of expression of these receptors in the brain regions involved in food intake and BW regulation might be sex-specific; systematic investigations are required to clarify this point. Elucidation of the neuronal mechanisms involved in the sex-specific effects of RLN3 on food intake and BW gain may reveal a novel pharmacological strategy for the Figure 4 The levels of expression of RXFP3 receptor mRNA in the PVN in male and female rats (n = 6) maintained on ad libitum chow in non-stressful conditions. (A) Optical density (OD) of the hybridization signal of RXFP3 receptor mRNA. Positive hybridization signal of RXFP3 receptor mRNA is shown on the dark-field micrographs in the PVN in male (B) and female (C) rats. *P < 0.05: significantly different compared with male rats. 3v, third ventricle. Scale bar, 300 μm.
Figure 5
Relative changes induced by i.c.v. administration of RLN3 in the brain and on food intake and BW gain in female rats compared with male rats. The upward and downward arrows show relatively high or low, respectively, effects produced in female rats compared with male rats.
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treatment of metabolic and eating disorders, which show a sex-specific propensity and incidence in humans.
